Clinical Trial Update: Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on autologous preconditioned bone marrow mesenchymal stem cells for ischemic heart disease, evaluated in Phase 1 and Phase 2 with status n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Cardiomyopathy
• Ischemic Heart Disease
• Myocardial Infarction

Drugs mentioned

• Autologous preconditioned bone marrow-derived mesenchymal stem cells (BMMSCs) (bone marrow mesenchymal stem cells)

Snippet

Sponsor: Academy Military Medical Science, China | Conditions: Myocardial Infarction, Acute Myocardial Infarction | Phase 1, Phase 2 | Status: UNKNOWN